Long-term Response in Advanced Colorectal Cancer
Long-term Response in Advanced Colorectal Cancer
A video update from Prof. Gerald Prager
A video update from Prof. Gerald Prager
Assoc. Prof. Gerald Prager
GI CONNECT expert Prof. Gerald Prager shares an update on what HCPs must consider to achieve a long-term response in advanced colorectal cancer (CRC). Watch the video and download the accompanying slides to understand:
-
How to view CRC treatment as a continuum of care
-
What to consider when making treatment decisions
-
Which treatment options are available for CRC patients, 3rd line and beyond
After completing this programme, deepen your understanding of this topic with the interactive patient case study Long-term Management of Advanced CRC from Prof. Gerald Prager and Prof. Joleen Hubbard.
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Long term response in mCRC
Video | 
4 min
|
Sep 2023
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Clinical Takeaways
-
Treatment of advanced colorectal cancer (CRC) should be considered as a continuum of care, and patients should be offered as many life-prolonging therapies as possible
-
Decision-making at each stage of therapy should consider patients' suitability and tolerability, tumour biomarkers and prior exposure to chemotherapies and/or targeted agents
-
There are a number of treatment options for CRC patients 3rd line and beyond that should be considered, such as regorafenib, trifluridine/tipiracil as well as consideration of clinical trials and rechallenge with chemotherapy or anti-EGFR
This educational programme is supported by an Independent Medical Education Grant from Bayer.
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
2 min
Other programmes developed by Assoc. Prof. Gerald Prager
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
